ALIGNMENT HEALTHCARE INC (ALHC)
US01625V1044 - Common Stock
ALHC gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 117 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of ALHC have multiple concerns. ALHC is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
ALHC had negative earnings in the past year.
ALHC had a negative operating cash flow in the past year.
In the past 5 years ALHC always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: ALHC reported negative operating cash flow in multiple years.
1.2 Ratios
ALHC has a worse Return On Assets (-25.01%) than 76.72% of its industry peers.
ALHC has a Return On Equity of -94.31%. This is in the lower half of the industry: ALHC underperforms 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -25.01% | ||
| ROE | -94.31% | ||
| ROIC | N/A |
ROA(3y)-26.52%
ROA(5y)-21.89%
ROE(3y)-73.64%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ALHC's Gross Margin of 11.02% is on the low side compared to the rest of the industry. ALHC is outperformed by 76.72% of its industry peers.
ALHC's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALHC so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 11.02% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.99%
GM growth 5YN/A
2. Health
2.1 Basic Checks
ALHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALHC has been increased compared to 1 year ago.
ALHC has a worse debt/assets ratio than last year.
2.2 Solvency
ALHC has an Altman-Z score of 3.20. This indicates that ALHC is financially healthy and has little risk of bankruptcy at the moment.
ALHC has a better Altman-Z score (3.20) than 74.14% of its industry peers.
A Debt/Equity ratio of 1.03 is on the high side and indicates that ALHC has dependencies on debt financing.
ALHC's Debt to Equity ratio of 1.03 is on the low side compared to the rest of the industry. ALHC is outperformed by 63.79% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.03 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.2 |
ROIC/WACCN/A
WACC8.95%
2.3 Liquidity
A Current Ratio of 1.84 indicates that ALHC should not have too much problems paying its short term obligations.
ALHC has a better Current ratio (1.84) than 70.69% of its industry peers.
ALHC has a Quick Ratio of 1.84. This is a normal value and indicates that ALHC is financially healthy and should not expect problems in meeting its short term obligations.
ALHC's Quick ratio of 1.84 is fine compared to the rest of the industry. ALHC outperforms 74.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.84 | ||
| Quick Ratio | 1.84 |
3. Growth
3.1 Past
The earnings per share for ALHC have decreased by -5.06% in the last year.
Looking at the last year, ALHC shows a very strong growth in Revenue. The Revenue has grown by 21.75%.
EPS 1Y (TTM)-5.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25%
Revenue 1Y (TTM)21.75%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%43.14%
3.2 Future
Based on estimates for the next years, ALHC will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.40% on average per year.
ALHC is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.69% yearly.
EPS Next Y66.6%
EPS Next 2Y30.58%
EPS Next 3Y21.98%
EPS Next 5Y10.4%
Revenue Next Year23.99%
Revenue Next 2Y22.25%
Revenue Next 3Y21.98%
Revenue Next 5Y26.69%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
ALHC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ALHC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
ALHC's earnings are expected to grow with 21.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.58%
EPS Next 3Y21.98%
5. Dividend
5.1 Amount
ALHC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ALIGNMENT HEALTHCARE INC
NASDAQ:ALHC (7/26/2024, 7:16:01 PM)
After market: 8.93 0 (0%)8.93
-0.43 (-4.59%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.71B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -25.01% | ||
| ROE | -94.31% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 11.02% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover3.08
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.03 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.84 | ||
| Quick Ratio | 1.84 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-5.06%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y66.6%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)21.75%
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y